Comparative study of standards of mother tincture from wild and cultivated roots of Rauwolfia serpentina with the standards of H.P.I.

Background of the study - Rauwolfia serpentina, a medicinal plant renowned for its therapeutic properties. Rauwolfia serpentina, commonly known as Indian snakeroot, has been traditionally used in various medicinal systems for its potential in managing cardiovascular and neurological disorders. As the wild variety of rauwolfia is slowly getting extinct, it’s important to cultivate it but first we have to see if the cultivated ones are as same in constituents as the wild ones. The research focuses on evaluating the chemical constituents, pharmacological activities, and quality control parameters of Rauwolfia serpentina in comparison to the standards set by the H.P.I, which is a crucial reference for the preparation and standardization of homeopathic medicines in India. The comparative analysis not only contributes to the scientific understanding of Rauwolfia serpentina but also informs the potential integration of this medicinal plant into the framework of homeopathic formulations outlined by H.P.I.